Page last updated: 2024-09-04

vatalanib and Corneal Angiogenesis

vatalanib has been researched along with Corneal Angiogenesis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bock, F; Cursiefen, C; Dietrich, T; Hos, D; Kruse, FE; Onderka, J; Thierauch, KH1

Other Studies

1 other study(ies) available for vatalanib and Corneal Angiogenesis

ArticleYear
Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:5

    Topics: Animals; Cell Proliferation; Corneal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Graft Survival; Keratoplasty, Penetrating; Lymphangiogenesis; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phosphorylation; Phthalazines; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor Receptor-3

2008